Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Imaging hypoxia in tumors.

J R Ballinger¹

¹Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, England.

Seminars in Nuclear Medicine

|November 17, 2001

Summary

Hypoxia, or low oxygen, in tumors impacts radiotherapy response. Noninvasive imaging using hypoxia-targeting radiopharmaceuticals, like 1-123-IAZA and Cu-60-ATSM, shows promise for guiding cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adverse events in nuclear medicine - cause for concern?

European journal of nuclear medicine and molecular imaging·2012

Same author

Short- and long-term responses to molybdenum-99 shortages in nuclear medicine.

The British journal of radiology·2010

Same author

A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2009

Same author

The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies.

Clinical and experimental immunology·2007

Same author

Lymphatic transfer studies with immunoglobulin scintigraphy after axillary surgery.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007

Same author

Radiolabelled leukocytes for imaging inflammation: how radiochemistry affects clinical use.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2006

Area of Science:

Nuclear Medicine
Oncology
Radiotherapy

Background:

Hypoxia in tumors significantly affects radiotherapy outcomes.
Tumor hypoxia is heterogeneous and difficult to measure accurately.
Current invasive methods for hypoxia assessment are complex and not routinely used.

Purpose of the Study:

To review the development and clinical utility of noninvasive imaging agents for detecting tumor hypoxia.
To highlight the role of nuclear medicine in optimizing cancer therapy for hypoxic tumors.

Main Methods:

Review of radiopharmaceuticals targeting hypoxic tissues, primarily 2-nitroimidazoles and non-nitro bioreductive complexes.
Discussion of specific agents like F-18-fluoromisonidazole, I-123-iodoazomycin arabinoside (IAZA), Cu-60-ATSM, and Tc-99m butylene amineoxime (BnAO/HL91).
Evaluation of preliminary clinical data correlating imaging findings with radiotherapy response.

Main Results:

Several hypoxia-directed radiopharmaceuticals have been developed and labeled with various isotopes (F-18, Cu-64/67, I-123, Tc-99m).
1-123-IAZA and Cu-60-ATSM show preliminary correlation with radiotherapy response in clinical studies.
Noninvasive imaging offers potential for repeated measures and clinical utility.

Conclusions:

Noninvasive imaging with hypoxia-directed radiopharmaceuticals holds great clinical potential for cancer treatment.
Further preclinical and clinical studies are needed to validate these imaging methods.
Nuclear medicine is crucial for optimizing therapy in patients with hypoxic tumors.

Related Experiment Videos